Chief Medical Officer · Bicara Therapeutics Inc. · Common Stock
Side
SELL
Value
$104K
Shares
5,500
Price
$18.95
Executed
Mar 25, 2026
Disclosed
Mar 26, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Mar 25 executedMar 26, 2026 disclosed
BCAX · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+4 / 15
3 prior trades recorded in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Raben David filed this Form 4 reporting a open-market sale of BCAX on Mar 25, 2026. It became public on Mar 26, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Chief Medical Officer
Raben Davidcik:0002034679
Issuer
Bicara Therapeutics Inc.cik:0002023658
Revision history · 0
No field has changed since this record was first ingested.
